Aditya V Shreenivas (Aditya Shreenivas)

Years Active: 2022-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Aditya V Shreenivas, Filip Janku, Mohamed A Gouda, Hui-Zi Chen, Ben George, Shumei Kato, Razelle Kurzrock
ALK fusions in the pan-cancer setting: another tumor-agnostic target? NPJ precision oncology 7 (1) (2023)
Stephen K Tahir, Emiliano Calvo, Benedito Arruda Carneiro, Junichiro Yuda, Aditya V Shreenivas, Mojca Jongen-Lavrencic, Eelke H Gort, Kenichi Ishizawa, Daniel Morillo, Carla Biesdorf, Morey Smith, Dong Cheng, Monica Motwani, David Sharon, Tamar Uziel, Dimple A Modi, Fritz G Buchanan, Susan Morgan-Lappe, Bruno C Medeiros, Darren C Phillips
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood (2023)
Stephen K Tahir, Emiliano Calvo, Benedito Arruda Carneiro, Junichiro Yuda, Aditya V Shreenivas, Mojca Jongen-Lavrencic, Eelke H Gort, Kenichi Ishizawa, Daniel Morillo, Carla Biesdorf, Morey Smith, Dong Cheng, Monica Motwani, David Sharon, Tamar Uziel, Dimple A Modi, Fritz G Buchanan, Susan Morgan-Lappe, Bruno C Medeiros, Darren C Phillips
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood (2023)
Aditya V Shreenivas, Shumei Kato, Jingjing Hu, Catherine Skefos, Jason Sicklick, Razelle Kurzrock
Carcinoma of unknown primary: Molecular tumor board-based therapy. CA: a cancer journal for clinicians 72 (6) (2022)

Aditya V Shreenivas.css-eqlu8i{font-size:small;padding-left:4px;} (Aditya Shreenivas)